Safety and Efficacy of FTY720 in Adult Patients Who Receive a Kidney Transplant

Novartis

Status and phase: Completed; Phase 3

Conditions: Kidney Transplantation

Treatments: Drug: FTY720

Study type: Interventional

Funder types: Industry

Identifiers

NCT00099801

CFTY720A2307

Details and patient eligibility

About

The safety and efficacy of FTY720 is being evaluated in patients who receive a kidney transplant.

Sex: All

Ages: 18 to 65 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients undergoing their first kidney transplant
• Male or female age 18 to 65 years

Exclusion criteria

• Patients in need of second kidney transplant or multi-organ transplants.

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)